Summary
- Current Price
- As of today, ALNY price is $282.72, up +0.29% on
- Current Price All-Time High
- ALNY price is currently -42.95% below its historical high of $495.55 set on
- Market Cap
- ALNY current market cap is $38B, down -7.25% year-over-year
- PE Ratio
- ALNY current PE ratio is 67.18
- Revenue
- ALNY current annual revenue is $3.71B, up +65.19% year-over-year
- Next Earnings
- The next earnings release for ALNY is on
Profile
| Metric | Value |
|---|---|
| Full Name | Alnylam Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ALNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | |
| Website | alnylam.com |
| Employees | 2,230 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $282.72 | |
| Price, 1D Change | +0.29% | |
| Market Cap | $38B | |
| - | ||
| PE Ratio | 67.18 | |
| Beta | 0.60 | |
| Revenue | $4B | |
| Revenue, 1Y Change | +65.19% | |
| EPS | $2.33 | |
| EPS, 1Y Change | +206.91% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $2.33 | |
| EPS Estimate | N/A | $9.51 |
| EPS Est. Change | N/A | +308.03% |
| Revenue | $3.71B | |
| Revenue Estimate | N/A | $5.63B |
| Revenue Est. Change | N/A | +51.48% |
| Current Price | $282.72 | |
| Price Target | - | $429.00 |
| Price Tgt. Change | - | +51.74% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.18 | -$2.18 | -1,118.68% | |
| $4.79 | $2.33 | -51.38% | |
| $9.51 | N/A | +308.03% | |
| $13.77 | N/A | +490.91% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.24B | $2.25B | +0.57% | |
| $3.77B | $3.71B | -1.60% | |
| $5.63B | N/A | +51.48% | |
| $7.32B | N/A | +97.20% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -9.48% | |
| Price, 3Y | +40.26% | |
| Market Cap, 1Y | -7.25% | |
| Market Cap, 3Y | +50.73% | |
| Revenue, 1Y | +65.19% | |
| Revenue, 3Y | +258.00% | |
| EPS, 1Y | +206.91% | |
| EPS, 3Y | +125.06% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $282.72 | |
| SMA 200 | $375.24 | |
| SMA 50 | $301.53 | |
| EMA 200 | $336.86 | |
| EMA 50 | $301.44 | |
| MACD | -$4.36 | |
| Beta | 0.60 | |
| ATR | $10.25 | |
| 14-Day RSI | 41.40 | |
| 10-Day Volatility | 36.41% | |
| 1-Year Volatility | 37.16% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $3.71B | |
| EPS | $2.33 | |
| Gross Profit | $3.03B | |
| Gross Margin | 81.64% | |
| Operating Income | $501.58M | |
| Operating Margin | 13.51% | |
| Net Income | $313.75M | |
| Net Margin | 8.45% | |
| EBITDA | $557.24M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 3.76 | |
| 2.76 | ||
| 2.71 | ||
| - | ||
| 6 | ||
| 5.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 67.18 | |
| 8.81 | ||
| 35.10 | ||
| 46.73 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $789.18M | |
| $2.91B | ||
| $5.03B | ||
| $4.05B | ||
| $4.24B | ||
| $1.47B | ||
| Total Debt | $2.97B | |
| $265.59M | ||
| $115.72M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $3.40B | ||
| $2.53B | ||
| $681.87M | ||
| $1.21B | ||
| $55.66M | ||
| $0.00 | ||
| $9.41M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $524.08M | ||
| $436.33M | ||
| -$305.19M | ||
| Capex | $58.70M | |
| $465.38M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Citigroup | ||
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ALNY
FAQ
What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?
The ticker symbol for Alnylam Pharmaceuticals, Inc. is NASDAQ:ALNY
Does Alnylam Pharmaceuticals, Inc. pay dividends?
No, Alnylam Pharmaceuticals, Inc. does not pay dividends
What sector is Alnylam Pharmaceuticals, Inc. in?
Alnylam Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Alnylam Pharmaceuticals, Inc. in?
Alnylam Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Alnylam Pharmaceuticals, Inc. based in?
Alnylam Pharmaceuticals, Inc. is headquartered in United States
When did Alnylam Pharmaceuticals, Inc. go public?
Alnylam Pharmaceuticals, Inc. initial public offering (IPO) was on June 1, 2004
Is Alnylam Pharmaceuticals, Inc. in the S&P 500?
No, Alnylam Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?
Yes, Alnylam Pharmaceuticals, Inc. is included in the NASDAQ 100 index
Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?
No, Alnylam Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Alnylam Pharmaceuticals, Inc. last earnings report?
Alnylam Pharmaceuticals, Inc.'s most recent earnings report was on April 30, 2026
When does Alnylam Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Alnylam Pharmaceuticals, Inc. is July 30, 2026
Data Sources & References
- ALNY Official Website www.alnylam.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1178670/000162828026007497/0001628280-26-007497-index.htm
- List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
- ALNY Profile on Yahoo Finance finance.yahoo.com/quote/ALNY
- ALNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alny